Sorry, you need to enable JavaScript to visit this website.
Skip to main content

This site is intended only for healthcare professionals resident in the United Kingdom

Pfizer UK offers a diverse portfolio of medicines across a broad range of therapeutic areas and are committed to supporting the appropriate use of these medicines to improve patient outcomes. Join us at one of our promotional virtual meetings to learn more.

The promotional meetings below are organised and funded by Pfizer and may include reference to Pfizer medicines relevant to agenda topics. Prescribing information to the relevant medicine can be found underneath the meeting information. Adverse event reporting can be found at the bottom of the page.


Live webinars

22 Jun
12:00
24 Jun
18:30
Anti-Infectives
  • ZAVICEFTA®(ceftazidime and avibactam)
Managing MDR Gram-negative infection: a multidisciplinary patient case study

Managing MDR Gram-negative infection: a multidisciplinary patient case study

This virtual promotional meeting is organised and funded by Pfizer Ltd

Dr Julie Samuel
Consultant Microbiologist, The Newcastle upon Tyne Hospitals NHS Foundation Trust
Lisa Nwankwo
Specialist Pharmacist, Antimicrobials, The Royal Brompton and Herefield NHS Trust
Duration
1 Hr
Audience
Consultants
Pharmacists
SpRs
Register Here
24 Jun
13:00
Cardiology, NVAF
  • ELIQUIS®(apixaban) - NVAF
Basics of ECG Interpretation

Basics of ECG Interpretation

This virtual promotional meeting is organised and funded by Pfizer Ltd on behalf of the Bristol Myers Squibb - Pfizer Alliance

Dr Rajesh Chelliah
Consultant Cardiologist, University Hospitals of Leicester NHS Trust
Duration
1 Hr 30
Audience
GPs
Nurses
Pharmacists
Register Here
24 Jun
19:00
Cardiology, Haematology, NVAF, VTE
  • ELIQUIS®(apixaban) - NVAF & VTE
Valuable Insights into Good Practise for the Treatment of NVAF and VTE from Merseyside Based Clinical Pharmacist and Respiratory Consultant

Valuable Insights into Good Practise for the Treatment of NVAF and VTE from Merseyside Based Clinical Pharmacist and Respiratory Consultant  

This promotional and virtual meeting is organised and funded by Pfizer Ltd on behalf of the Bristol Myers Squibb - Pfizer Alliance

Dr Biswajit Chakrabarti
Respiratory Consultant, University Hospital Aintree
Mrs Lynne Garforth
Clinical Pharmacist and Independent Prescriber, Ashburton Prescribing Consultants
Duration
2 Hrs
Audience
Consultants
GPs
Nurses
Pharmacists
SpRs
Register Here
25 Jun
13:00
NVAF, VTE, Cardiology, Endocrine, Lung Cancer, Smoking Cessation, Dermatology, Gastroenterology, Pain Management, Vaccines, Anti-Infectives, Haematology, Renal Cancer, Breast Cancer, Haem Oncology, Rheumatology
  • IBRANCE®(palbociclib)
Working virtually in the NHS “Remote not Distant - Embracing the Gap”

Working virtually in the NHS “Remote not Distant - Embracing the Gap”

This virtual promotional meeting is organised and funded by Pfizer Ltd

Professor Robert Copeland
Professor and Director - Advanced Wellbeing Research Centre and National Centre for Sport and Exercise Medicine, Sheffield Hallam University
Dr Micheál O’Cathail
Consultant Clinical Oncologist, Head of Service for Oncology, Nottingham University Hospitals NHS Trust
Dr Peter Thomas
Director of Digital Innovation and Consultant Paediatric, Ophthalmologist at Moorfields Eye Hospital NHS FT
Dr Laura Pettit
Consultant Clinical Oncologist, Shrewsbury and Telford NHS Trust
Duration
1 Hr 50
Audience
Consultants
GPs
Nurses
Pharmacists
SpRs
Register Here
29 Jun
18:15
Haematology
  • BeneFIX®(nonacog alfa)
  • ReFacto AF®(moroctocog alfa) 
Moving on - Considerations for Haemophilia Patients post Covid

Moving on - Considerations for Haemophilia Patients post Covid

This virtual promotional meeting is organised and funded by Pfizer Ltd

Ms Catherine Harrison
Advanced Nurse Practitioner, Sheffield Haemophilia and Thrombosis Centre
Dr David Stephensen
Specialist Physiotherapist, Kent Haemophilia and Thrombosis Centre
Dr Rachel Attfield
Clinical Psychologist, Sheffield Haemophilia and Thrombosis Centre
Duration
1 Hr
Audience
Nurses
Other (HCP)
Register Here
29 Jun
18:30
Gastroenterology
  • XELJANZ®(tofacitinib citrate)
The Science of JAK Inhibition and Pivotal Studies of XELJANZ®(tofacitinib citrate) in Ulcerative Colitis

The Science of JAK Inhibition and Pivotal Studies of XELJANZ®(tofacitinib citrate) in Ulcerative Colitis

This virtual promotional meeting is organised and funded by Pfizer Ltd

Professor Gordon Moran
Clinical Associate Professor, Faculty of Medicine & Health Sciences, Nottingham University Hospitals NHS Trust
Duration
1 Hr
Audience
Consultants
Nurses
Pharmacists
SpRs
Register Here

FAQ

See if our bank of frequently asked questions solves your query. If not, use our online enquiry form to get in touch